SEATTLE CHILDREN'S HOSPITAL
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Success in Health: Impacting Families Together
Not Applicable
Completed
- Conditions
- Childhood Obesity
- Interventions
- Behavioral: FBT for Pediatric Weight Management by ProfessionalsBehavioral: FBT for Pediatric Weight Management by PeersBehavioral: Peer Interventionists
- First Posted Date
- 2015-10-20
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 242
- Registration Number
- NCT02580162
- Locations
- πΊπΈ
Seattle Children's, Seattle, Washington, United States
Fecal Microbiota Transplantation as a Strategy to Eradicate Resistant Organisms
Phase 1
Recruiting
- Conditions
- Infection Resistant to Drugs
- Interventions
- Biological: Fecal Microbiota Transplantation
- First Posted Date
- 2015-09-07
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT02543866
- Locations
- πΊπΈ
Seattle Children's Hospital, Seattle, Washington, United States
Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia
- First Posted Date
- 2015-08-20
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 7
- Registration Number
- NCT02529202
- Locations
- πΊπΈ
Seattle Children's Hospital, Seattle, Washington, United States
Brain Activation and Satiety in Children: Functional Magnetic Resonance Imaging
Not Applicable
Completed
- Conditions
- Childhood Obesity
- Interventions
- Behavioral: Family Based Behavioral Treatment
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 81
- Registration Number
- NCT02484976
- Locations
- πΊπΈ
Seattle Childrens Hospital, Seattle, Washington, United States
mHealth Intervention to Promote Cancer Survivors' Physical Activity
Not Applicable
Completed
- Conditions
- Physical ActivityQuality of Life
- Interventions
- Behavioral: FitbitBehavioral: Facebook group
- First Posted Date
- 2015-06-11
- Last Posted Date
- 2016-10-13
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT02469727
- Locations
- πΊπΈ
Seattle Children's Research Institute, Seattle, Washington, United States
A Pilot RCT of the PRISM Intervention for AYAs With Cancer
Phase 2
Completed
- Conditions
- Acute Myelogenous LeukemiaLymphomaBrain TumorsGerm Cell TumorAcute Lymphoblastic LeukemiaSarcomaCancer
- Interventions
- Behavioral: Promoting Resilience In Stress Management (PRISM)
- First Posted Date
- 2015-01-19
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 92
- Registration Number
- NCT02340884
- Locations
- πΊπΈ
Seattle Children's Hospital, Seattle, Washington, United States
Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass
Phase 3
Completed
- Conditions
- Congenital Heart Defects
- Interventions
- Drug: TriostatDrug: Placebo
- First Posted Date
- 2014-12-19
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 220
- Registration Number
- NCT02320669
- Locations
- πΊπΈ
Los Angeles Children's Hospital, Los Angeles, California, United States
πΊπΈLucille Packard Children's Hospital, Palo Alto, California, United States
πΊπΈSeattle Children's Hospital, Seattle, Washington, United States
Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes
Phase 1
Completed
- Conditions
- Malaria
- Interventions
- Biological: GAP3KO
- First Posted Date
- 2014-12-10
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT02313376
- Locations
- πΊπΈ
Seattle Biomedical Research Institute Malaria Clinical Trial Center, Seattle, Washington, United States
Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01
Phase 1
Active, not recruiting
- Conditions
- NeuroblastomaGanglioneuroblastoma
- Interventions
- Biological: Patient Derived CD171 specific CAR T cells expressing EGFRt (2nd generation T cells)Biological: Patient Derived CD171 specific CAR T cells expressing EGFRt (3rd generation T cells)Biological: Patient Derived CD171 specific CAR T cells expressing EGFRt (long spacer 2nd generation T cells)
- First Posted Date
- 2014-12-08
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 65
- Registration Number
- NCT02311621
- Locations
- πΊπΈ
Seattle Children's Hospital, Seattle, Washington, United States
Fecal Microbial Transplant in Pediatric Crohn's Disease
Phase 1
Terminated
- Conditions
- Crohn's Disease
- Interventions
- Biological: Fecal Microbial transplantDrug: Normal SalineDrug: rifaximin+omeprazole+miralax
- First Posted Date
- 2014-10-23
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 7
- Registration Number
- NCT02272868
- Locations
- πΊπΈ
Seattle Children's Hospital, Seattle, Washington, United States
Β© Copyright 2025. All Rights Reserved by MedPath